Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 13/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.61 |
| ▸ | NR3C1 | P04150 | 5/20 | 0.61 |
| ▸ | PGR | P06401 | 5/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.61 |
| ▸ | SERPINA6 | P08185 | 3/20 | 0.61 |
| ▸ | NR3C2 | P08235 | 3/20 | 0.61 |
| ▸ | AR | P10275 | 2/20 | 0.61 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.61 |
| ▸ | TNF | P01375 | 1/20 | 0.61 |
| ▸ | IL6 | P05231 | 1/20 | 0.61 |
| ▸ | GLUL | P15104 | 1/20 | 0.61 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.61 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.61 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | SHBG | P04278 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7095395 | 0.99 | HIF1A (0.61) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL264554 | 0.97 | HIF1A (0.64) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL945988 | 0.96 | HIF1A (0.65) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL27748218 | 0.93 | HIF1A (0.61) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL11068491 | 0.92 | HIF1A (0.62) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL27781029 | 0.92 | HIF1A (0.66) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL122048 | 0.91 | HIF1A (0.63) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL677626 | 0.91 | HIF1A (0.61) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL7999837 | 0.91 | HIF1A (0.57) | HIF1AHSD17B10NR3C1PGRCYP3A4 | |
| SCHEMBL22042713 | 0.91 | HIF1A (0.59) | HIF1AHSD17B10NR3C1PGRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 253 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-10072352-A | — | — | None | — | — | JP | disclosed |
| JP-10072352-A | — | — | None | — | — | JP | disclosed |
| US-20250302755-A1 | COATABLE CORE FOR A MODIFIED RELEASE DRUG FORMULATION | TILLOTTS PHARMA AG (CH) | 2025-10-02 | — | — | US | disclosed |
| US-12370146-B2 | Method of producing a delayed release drug formulation | TILLOTTS PHARMA AG (CH) | 2025-07-29 | — | — | US | disclosed |
| US-12370147-B2 | Coatable core for a modified release drug formulation | TILLOTTS PHARMA AG (CH) | 2025-07-29 | — | — | US | disclosed |
| CN-119731370-A | Method and system for coating a drug container, cleaning a drug container and checking a drug container for particles and defects | 二氧化硅医疗产品公司 | 2025-03-28 | — | — | CN | disclosed |
| EP-3662901-B1 | DELAYED RELEASE DRUG FORMULATION COMPRISING AN OUTERLAYER WITH AN ENZYMATICALLY DEGRADABLE POLYMER, ITS COMPOSITION AND ITS METHOD OF MANUFACTURING | TILLOTTS PHARMA AG (CH) | 2025-01-01 | — | — | EP | disclosed |
| EP-3187171-B1 | A DELAYED RELEASE DRUG FORMULATION | TILLOTTS PHARMA AG (CH) | 2024-09-25 | — | — | EP | disclosed |
| CN-118451193-A | Method for removing embedding agent from embedding sample | 基金会医学公司 | 2024-08-06 | — | — | CN | disclosed |
| EP-3662902-B1 | COLONIC DRUG DELIVERY FORMULATION | TILLOTTS PHARMA AG (CH) | 2024-07-31 | — | — | EP | disclosed |
| WO-1998029101-A1 | PHARMACEUTICAL PREPARATIONS OF GLUTATHIONE AND METHODS OF ADMINISTRATION THEREOF | ANTIOXIDANT PHARMACEUTICALS CORPORATION (US) | 1998-07-09 | — | — | WO | disclosed |
| JP-H1072352-A | INFECTION SOLUTION OF PREDNISOLONE SODIUM METHYL SUCCINATE | NIPPON KAYAKU CO LTD | 1998-03-17 | — | — | JP | disclosed |
| JP-H1072352-A | INFECTION SOLUTION OF PREDNISOLONE SODIUM METHYL SUCCINATE | NIPPON KAYAKU CO LTD | 1998-03-17 | — | — | JP | disclosed |
| WO-1997015298-A1 | COMBINATION OF LTD, RECEPTOR ANTAGONISTS WITH GLUCOCORTICOSTEROIDS | BAYER AKTIENGESELLSCHAFT (DE) | 1997-05-01 | — | — | WO | disclosed |
| WO-1997010224-A1 | BENZOXAZEPINE COMPOUNDS, THEIR PRODUCTION AND USE AS LIPID LOWERING AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1997-03-20 | — | — | WO | disclosed |
| US-4855325-A | Treatment of mammals suffering from damage to the central nervous system | NAFTCHI NOSRAT E (US) | 1989-08-08 | — | — | US | disclosed |
| US-4742054-A | Treatment of mammals suffering from damage to the central nervous system | NAFTCHI NOSRAT E (US) | 1988-05-03 | — | — | US | disclosed |
| US-4406883-A | SHAPES | MERRELL DOW PHARMACEUTICALS INC. (US) | 1983-09-27 | — | — | US | disclosed |
| US-4292300-A | METHYL CELLULOSE, WATER, DRUG | INVERESK RESEARCH INTERNATIONAL (GB) | 1981-09-29 | — | — | US | disclosed |
| US-4265875-A | HYDROXYPROPYL METHYL CELLULOSE | INVERESK RESEARCH INTERNATIONAL (GB) | 1981-05-05 | — | — | US | disclosed |